Understanding the Covid-19 vaccine strategy
Thursday 28 January 2021
This webinar aimed to help psychiatrists and other frontline healthcare workers understand some of the thinking behind the vaccine roll-out and the key issues to consider when offering the vaccine to those with a severe mental illness, intellectual disability and/or dementia.
Topics covered
- Overview of the vaccination programme
- Insight into how decisions should be made about the administering of vaccines
- Discussion around some of the ways capacity to consent has been addressed with patients
Speakers
- Dr Adrian James - President of Royal College of Psychiatrists
- Dr Jonathan Leach OBE - NHS England Medical Director for COVID-19 Immunisation
- Mr Alex Ruck Keene - Barrister and Visiting Senior Lecturer at King’s College London
- Dr Mani Krishnan - Chair of the Faculty of Old Age Psychiatry at the Royal College of Psychiatrists
- Dr Ken Courtenay - Chair of the Faculty of the Psychiatry of Intellectual Disability
- Dr Victoria Sullivan - Consultant Forensic Psychiatrist
Each of the speakers gave a short presentation on their area of expertise and this was then followed by a Q&A from the audience, which was chaired by Adrian James.
Useful resources
- Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
- Spectrum, Risk Factors, and Outcomes of Neurological and Psychiatric Complications of COVID-19: A UK-Wide Cross-Sectional Surveillance Study (under review in Lancet Neurology)
- COVID-19 Vaccination and the MCA – the first Court of Protection judgment (The E case is here)
- Useful tips on the Covid-19 vaccine for people with dementia (Dementia UK)
- 39 Essex Chambers: Rapid response guidance note: Vaccination and Mental Capacity
Read more
to receive further information regarding a career in psychiatry